Search
- Report
In this report, CBO provides background on the methods used to estimate the costs of antifraud legislation.
- Working Paper
Although the Medicare Part D program generally encourages plan sponsors to submit low bids, this paper explores rules relating to low-income beneficiaries that generate a different set of incentives for plans that serve those beneficiaries.
- Working Paper
CBO releases a companion working paper to its report Competition and the Cost of Medicare’s Prescription Drug Program.
- Report
Why has Medicare's prescription drug program cost less than anticipated when the program was created? How has competition between plan sponsors affected spending? How do Medicare Part D drug prices compare to those in Medicaid?
- Blog Post
After the release of The 2014 Long-Term Budget Outlook, a number of people asked for more information about how much CBO has revised projected federal health care spending during the past several years. This post answers their questions.
- Blog Post
Three factors explain the projected substantial growth in a few of the government’s large programs: the aging of the population, rising health care spending per beneficiary, and the ACA’s expansion of federal subsidies for health insurance.
- Presentation
To get a quick overview of CBO's report The 2014 Long-Term Budget Outlook, check out this slide deck.
- Report
Testimony before the Committee on the Budget, U.S. House of Representatives.
- Report
If current laws remained generally unchanged, federal debt held by the public would exceed 100 percent of GDP by 2039 and would be on an upward path relative to the size of the economy—a trend that could not be sustained indefinitely.
- Presentation
Presentation by Rob Stewart, CBO Analyst, to the Alliance for Health Reform